Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk R Schultz

Showing results (1-10 of 217) with videos related to

Pageof 22
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Is any donor too old?Kirk R Schultz
Pediatric Hematology and Oncology|July 11, 2019
Too stressed for tests? Challenges of diagnosing psychological distress in pediatric cancer patients and survivorsKirk R Schultz
Blood|May 1, 2010
Haploidentical transplantation in childrenKirk R Schultz
Blood|October 5, 2013
STAT3 mutations and persistence of autoimmunityKirk R Schultz
Expert Review of Hematology|June 15, 2011
Biomarkers in chronic graft-versus-host diseaseJacob Rozmus, Kirk R Schultz
Transplantation and Cellular Therapy|July 2, 2022
When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?Sonali Chaudhury, Kirk R Schultz
Haematologica|May 26, 2022
Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?Steven Z Pavletic, Kirk R Schultz
Expert Review of Hematology|November 25, 2010
Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment optionsKirk R Schultz, Tim Prestidge, Bruce Camitta
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?Meinolf Suttorp, Isaac Yaniv, Kirk R Schultz
Pediatric Clinics of North America|March 24, 2010
Chronic graft-versus-host disease (GVHD) in childrenKristin Baird, Kenneth Cooke, Kirk R Schultz
Pageof 22

Showing results (1-10 of 217) with videos related to

Sort By:
Pageof 22
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Is any donor too old?Kirk R Schultz
Pediatric Hematology and Oncology|July 11, 2019
Too stressed for tests? Challenges of diagnosing psychological distress in pediatric cancer patients and survivorsKirk R Schultz
Blood|May 1, 2010
Haploidentical transplantation in childrenKirk R Schultz
Blood|October 5, 2013
STAT3 mutations and persistence of autoimmunityKirk R Schultz
Expert Review of Hematology|June 15, 2011
Biomarkers in chronic graft-versus-host diseaseJacob Rozmus, Kirk R Schultz
Transplantation and Cellular Therapy|July 2, 2022
When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?Sonali Chaudhury, Kirk R Schultz
Haematologica|May 26, 2022
Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?Steven Z Pavletic, Kirk R Schultz
Expert Review of Hematology|November 25, 2010
Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment optionsKirk R Schultz, Tim Prestidge, Bruce Camitta
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?Meinolf Suttorp, Isaac Yaniv, Kirk R Schultz
Pediatric Clinics of North America|March 24, 2010
Chronic graft-versus-host disease (GVHD) in childrenKristin Baird, Kenneth Cooke, Kirk R Schultz
Pageof 22